Schrödinger

New York, United States Founded: 1990 • Age: 36 yrs Listed Acquired By Baron Funds
Schrödinger is recognized for developing physics-based software platforms for molecular discovery.

About Schrödinger

Schrödinger is a company based in New York (United States) founded in 1990 by William A Goddard was acquired by Baron Funds in May 2020. It operates as a SaaS (Software-as-a-Service) and Professional Services. Schrödinger has raised $162 million across 10 funding rounds from investors including WuXi AppTec, Gates Foundation and HHS. The company has 891 employees. Schrödinger offers products and services including Maestro, LiveDesign, MS Maestro, and FEP+. Schrödinger operates in a competitive market with competitors including Nimbus Therapeutics, PhaseCraft, Cradle, EvolutionaryScale and Evozyne, among others.

  • Headquarter New York, United States
  • Employees 891
  • Founders William A Goddard
  • Stage Public
  • Sectors
    Industrial Goods & Manufacturing
    Healthcare Technology
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website schrodinger.com
  • Social LinkedIn X Instagram
  • Acquired by Baron Funds (May 2020)
  • Legal Name Schrodinger, Inc.
Key Metrics
  • Annual Revenue
    ₹138 Cr

    FY 2025 · +21% YoY

  • Net Profit
    ₹18.25 Cr

    FY 2025 · 13% margin

  • EBITDA
    ₹31.09 Cr

    FY 2025 · 22% margin

  • Total Equity Funding
    $162M (USD)

    in 10 rounds

  • Latest Funding Round
    $4.9M (USD), Grant

    Nov 2021

  • Investors
    WuXi AppTec

    & 11 more

  • Employee Count
    891
  • Acquired by
    Baron Funds

    (May 2020)

Products & Services of Schrödinger

Schrödinger offers a comprehensive portfolio of products and services, including Maestro, LiveDesign, MS Maestro, and FEP+.

Maestro
Life Science Software

Software for molecular modeling in drug discovery research.

LiveDesign
Life Science Software

Platform for collaborative drug design and data management.

MS Maestro
Materials Science Software

Tool for molecular modeling in materials science applications.

FEP+
Life Science Software

Software for free energy calculations in drug design.

Funding Insights of Schrödinger

Schrödinger has successfully raised a total of $162M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $4.9 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $162M
  • Total Rounds 10
  • Last Round Grant — $4.9M
  • First Round $1.04M

    (Jan 2007)

  • Investors Count 12

All 10 funding rounds of Schrödinger with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2021$4.9MGrant––
May 2019$110MSeries D–Gates Foundation, WuXi AppTec
Jun 2015$22MSeries C––
–
Jan 2015$377,710Grant––
Dec 2012$20MAngel Round–Bill Gates
–
Sep 2010$1.04MGrant––
Apr 2010$10MSeries A––
–
Mar 2009$300,843Grant––
Apr 2008$300,843Grant––
Jan 2007$1.04MGrant––
Valuation history

12 investors in total: 11 institutional and 1 angel.

Investors in Schrödinger

Schrödinger has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include WuXi AppTec, Gates Foundation and HHS.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Healthcare ecosystem is supported through investment and innovation by Deerfield.
–deerfield.comNew York, United States
Venture capital investments are directed toward multiple sectors.
2006qimingvc.comShanghai, China
Corporate backed venture capital fund investing in multiple sectors
–gv.comMountain View, United States
Growth-stage companies are invested in by this venture capital fund.
–pavilioncapital.comNew York, United States
Long-term private equity investments in transformational opportunities are pursued.
–invus.comNew York, United States
Charitable foundation investments on poverty reduction and healthcare
2000gatesfoundation.orgSeattle, United States
Provider of CRO and CDMO services
2000wuxiapptec.comShanghai, China
Asset management services for growth equity investments through mutual funds and strategies.
–baronfunds.com-
Offers capital markets investing through qualitative and quantitative research across asset classes.
2005laurioncap.comNew York, United States
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Schrödinger

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Schrodinger India Private Limited (Schrödinger)

Schrodinger India Private Limited is the primary company behind Schrödinger. The board of Schrodinger India Private Limited currently have 4 directors; the longest-serving is Puja Khemka, appointed in 2021. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Puja Khemka
DIN 08500093
Whole-time director24 Sep 20215 yrsSchrodinger India Private Limited
Kenneth Patrick Lorton
DIN 09332875
Director24 Sep 20215 yrsSchrodinger India Private Limited
Yvonne Kim Tran
DIN 09332876
Director24 Sep 20215 yrsSchrodinger India Private Limited
Ramakrishna Annabhimoju
DIN 11515644
Additional Director05 Feb 20268 moSchrodinger India Private Limited

People of Schrödinger

199 people are tracked at Schrödinger (84 in leadership, 13 in board & advisors, 102 in team); the tracked headcount is 891.

NameRoleGroup
William A Goddard
Co-FounderLeadership
Ramy Farid
CEO & PresidentLeadership
Tomoko Satoh
VP, Representative Director, Japan OperationsLeadership
Christiane Braun
Director Marketing EuropeLeadership
Karen Akinsanya
EVP, Chief Biomedical Scientist, Head of Discovery R&DLeadership
EVP & Chief Legal OfficerLeadership
Michelle King
Director Of Growth, Material ScienceLeadership
Naveen Kumar Thakral
Sr. Director, Pharmaceutical SciencesLeadership
Adrian Komainda
Executive Director Materials Science Business EMEALeadership
Helge Weissig
Senior Director, Discovery InformaticsLeadership
Mathew D. Halls
VP, Materials ScienceLeadership
Margaret Dugan
Chief Medical OfficerLeadership
Jacquelynne Romo
Senior Director, SalesLeadership
SVP & CTOLeadership
Richie Jain
SVP, Strategic Finance & Head of Corporate & Business DevelopmentLeadership
James Baxendale
VP Enterprise InformaticsLeadership
Dan Cannon
Director, Head Of Biologics ModellingLeadership
Adam Levinson
Director, Medicinal ChemistryLeadership
Zachary Johnson
Senior Director Of Structural BiologyLeadership
Saleem Abdullahi
Executive Assistant To SVP & Chief Biomedical Scientist And Svp, ScienceLeadership

179 more people are available in the full profile.

Premium access

Complete people profiles for Schrödinger

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Schrödinger

Schrödinger is a publicly listed company on the NASDAQ with ticker symbol SDGR in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date06 Feb 2020
  • Listed onNASDAQ: SDGR
  • Listed entitySchrodinger, Inc.
  • Exchange sectorTechnology services
  • ISINUS80810D1037
  • Share price$27.28 (+3.37% on the day) · 2026-10-09
  • Market capitalisation$2.04B
  • EPS (diluted, trailing year)$-0.74
  • Volume (last session)2,080,247

Financials of Schrödinger

Figures of Schrodinger India Private Limited, the primary company behind Schrödinger, for FY 2025. Revenue was ₹138 Cr (+21% year on year). Net profit was ₹18.25 Cr (13% margin). EBITDA was ₹31.09 Cr (22% margin). Revenue has grown at a compounded annual rate of +78% over three years.

  • ₹138 CrRevenue · FY 2025 · +21% YoY
  • ₹18.25 CrNet profit · 13% margin
  • ₹31.09 CrEBITDA · 22% margin
  • ₹37.50 CrPaid-up capital
  • 146Employees (provident fund records)
  • +78%Revenue CAGR, 3 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$255.9M-$103.3M-$160.9M
2024$207.5M-$187.1M-$203.1M
2023$216.7M$40.7M-$171.9M
2022$181.0M-$149.2M-$142.5M
2021$137.9M-$100.4M-$108.6M

Balance sheet, profit and loss, cash flow and ratios of Schrodinger India Private Limited are on its company page.

Premium access

Detailed financial statements for Schrödinger

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Schrödinger

5 dated milestones of Schrödinger across 31 years, from founding to its latest funding, stage changes and deals.

  1. Founded Schrödinger is founded.
  2. Funding First funding round of $1.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Exit Acquired by Baron Funds.
  5. Funding Latest funding round, Grant, of $4.9M.

Competitors of Schrödinger

Schrödinger operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, PhaseCraft, Cradle, EvolutionaryScale and Evozyne, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nimbustx.com2009Cambridge, United States$685M81
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
phasecraft.io2019Bristol, United Kingdom$56.42M13
Quantum simulation systems are provided for materials and chemical reactions.
cradle.bio2021Delft, Netherlands$102.71M–
Chemoproteomics solutions are provided for protein design and development.
evolutionaryscale.ai2023New York, United States$142M–
Provider of an AI models for protein design
evozyne.com2020Chicago, United States$144.37M–
Developer of proteins using protein engineering technology
profluent.bio2022Berkeley, United States$44M–
An AI-based protein design platform is provided for drug discovery.
frontiermeds.com2018San Francisco, United States$235.5M115
Bioinformatics platform is developed for drug discovery and chemoproteomics.
eikontx.com2019Hayward, United States$1.16B–
Protein dynamics are tracked and measured for drug discovery processes.
Premium access

Detailed competitors of Schrödinger

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Schrödinger

The website of Schrödinger (schrodinger.com) receives about 197.3K visits a month.

  • Monthly visits
    197.3K

    ▼ 4.5% vs previous month

Similar websites

Websites whose visitors overlap most with Schrödinger. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
chemcomp.com
100%
23.1K#1,100,676View details
acdlabs.com
98%
177.1K#258,053View details
eyesopen.com
90%
25.2K#1,006,842View details
daylight.com
daylight.com
82%
–#1,065,024–
hyper.com
79%
2.4K#8,363,100View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Schrödinger

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Schrödinger

Premium access

Complete news archive for Schrödinger

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Schrödinger

10 companies that operate in the same segment as Schrödinger (Materials Equipment & Tech), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Technology tools and systems for molecular scale are developed.
1959Abingdon, Oxfordshire, United Kingdom–USD 648.1 M–
Tech-interfaced procurement marketplace is operated for metal manufacturers.
2017Kolkata, West Bengal, IndiaUSD 17.19 MUSD 22.11 M48
Retailer of various steel products including mild, stainless, and structural
2020Mumbai, Maharashtra, IndiaUSD 91.54 M––
Provider of B2B platform for raw material procurement and credit access
2015Ahmedabad, Gujarat, IndiaUSD 776.04 MUSD 1.88 B940
Critical minerals are recovered from e-waste via electro-extraction technology.
2017Knoxville, Tennessee, United StatesUSD 65.23 M––
Provider of AI-based solutions for materials informatics
2013Redwood City, California, United StatesUSD 81.26 M–53
Zhaogang is recognized as a leading steel e-commerce platform.
2012Shanghai, ChinaUSD 393.8 M––
Digital microscopes for pathology and telepathology are developed.
2014Thane, Maharashtra, IndiaUSD 1.71 MUSD 229.8 K21
Novi is focused on enhancing AI-driven shopping experiences.
2019Larkspur, Colorado, United StatesUSD 51.65 M–16
3D printers are manufactured using nanotechnology for microdevice prototyping.
2018Kongens Lyngby, Capital Region, DenmarkUSD 30 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Schrödinger

Schrödinger was founded in 1990 and raised its 1st funding round 17 years after it was founded.

Schrödinger is headquartered in New York, United States. It is registered at New York, New York, United States.

Ramy Farid is the current CEO of Schrödinger.

Schrödinger is a funded company, having raised a total of $162M across 10 funding rounds to date. The company's 1st funding round was a Grant of $1.04M, raised on Jan 2007.

Schrödinger has 891 employees.

The primary company behind Schrödinger, Schrodinger India Private Limited, reported revenue of ₹138 Cr for FY 2025, up 21% year on year.

Schrödinger is engaged in creating computational platforms powered by physics to transform therapeutics and materials discovery. The company operates in life sciences and materials science sectors, offering solutions for drug discovery, biologics, and advanced materials design. Key areas include small molecule discovery, antibody design, and polymeric materials. Software products like Maestro, LiveDesign, and FEP are provided alongside services for collaborative research. The company also advances a proprietary pipeline of therapeutics targeting high-value, validated targets. Educational resources and certification courses are offered to support digital chemistry adoption across industries.

Schrödinger's top competitors include Nimbus Therapeutics, Cradle and Profluent Bio.

Schrödinger offers Maestro, LiveDesign, MS Maestro, and FEP+.

Yes, Schrödinger is publicly traded on NASDAQ under the ticker symbol SDGR.

Schrödinger has 12 investors. Key investors include WuXi AppTec, Gates Foundation, HHS, European Union, and Qiming Venture Partners.

Schrödinger operates through Schrodinger India Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available